This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Example SubstanceDefinition/her2 (Turtle)
Raw Turtle (+ also see Turtle/RDF Format Specification)
Protein substance: HER2 (ErbB2) — the target protein referenced by Trastuzumab
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
# Example: Human HER2/ErbB2 — the target protein of Trastuzumab.
# This example demonstrates a target substance that can be referenced
# by another SubstanceDefinition's .relationship.substanceDefinition.
<http://hl7.org/fhir/SubstanceDefinition/her2> a fhir:SubstanceDefinition ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "her2"] ; #
fhir:identifier ( [
fhir:system [
fhir:v "https://www.uniprot.org"^^xsd:anyURI ;
fhir:l <https://www.uniprot.org>
] ;
fhir:value [ fhir:v "P04626" ]
] ) ; #
fhir:status [
fhir:coding ( [
fhir:system [
fhir:v "http://hl7.org/fhir/publication-status"^^xsd:anyURI ;
fhir:l <http://hl7.org/fhir/publication-status>
] ;
fhir:code [ fhir:v "active" ] ;
fhir:display [ fhir:v "Active" ]
] )
] ; #
fhir:classification ( [
fhir:coding ( [
fhir:system [
fhir:v "http://example.europa.eu/fhir/SubstanceType"^^xsd:anyURI ;
fhir:l <http://example.europa.eu/fhir/SubstanceType>
] ;
fhir:code [ fhir:v "protein" ] ;
fhir:display [ fhir:v "Protein" ]
] )
] ) ; #
fhir:domain [
fhir:coding ( [
fhir:system [
fhir:v "http://example.europa.eu/fhir/Domain"^^xsd:anyURI ;
fhir:l <http://example.europa.eu/fhir/Domain>
] ;
fhir:code [ fhir:v "human" ] ;
fhir:display [ fhir:v "Human use" ]
] )
] ; #
fhir:description [ fhir:v "Human HER2 (ErbB2, receptor tyrosine-protein kinase erbB-2). A transmembrane receptor of the EGFR family, frequently overexpressed in breast and gastric cancers. The molecular target of trastuzumab and other HER2-directed therapies."] ; #
fhir:code ( [
fhir:code [
fhir:coding ( [
fhir:system [
fhir:v "https://www.uniprot.org"^^xsd:anyURI ;
fhir:l <https://www.uniprot.org>
] ;
fhir:code [ fhir:v "P04626" ] ;
fhir:display [ fhir:v "ERBB2_HUMAN" ]
] )
]
] ) ; #
fhir:name ( [
fhir:name [ fhir:v "Receptor tyrosine-protein kinase erbB-2" ] ;
fhir:preferred [ fhir:v true ] ;
fhir:language ( [
fhir:coding ( [
fhir:system [
fhir:v "urn:ietf:bcp:47"^^xsd:anyURI ;
fhir:l <urn:ietf:bcp:47>
] ;
fhir:code [ fhir:v "en" ] ;
fhir:display [ fhir:v "English" ]
] )
] )
] [
fhir:name [ fhir:v "HER2" ] ;
fhir:preferred [ fhir:v false ]
] [
fhir:name [ fhir:v "ErbB-2" ] ;
fhir:preferred [ fhir:v false ]
] [
fhir:name [ fhir:v "CD340" ] ;
fhir:preferred [ fhir:v false ]
] ) ; #
fhir:protein [
fhir:sequenceType [
fhir:coding ( [
fhir:system [
fhir:v "http://hl7.org/fhir/substance-sequence-type"^^xsd:anyURI ;
fhir:l <http://hl7.org/fhir/substance-sequence-type>
] ;
fhir:code [ fhir:v "complete" ] ;
fhir:display [ fhir:v "Complete" ]
] )
] ;
fhir:numberOfSubunits [ fhir:v 1 ] ;
fhir:subunit ( [
fhir:subunit [ fhir:v 1 ] ;
fhir:length [ fhir:v 1255 ]
] ) ;
fhir:gene ( [
fhir:sequenceOrigin [
fhir:coding ( [
fhir:system [
fhir:v "http://hl7.org/fhir/gene-sequence-origin"^^xsd:anyURI ;
fhir:l <http://hl7.org/fhir/gene-sequence-origin>
] ;
fhir:code [ fhir:v "human" ] ;
fhir:display [ fhir:v "Human" ]
] )
] ;
fhir:gene [
fhir:concept [
fhir:coding ( [
fhir:system [
fhir:v "http://www.genenames.org"^^xsd:anyURI ;
fhir:l <http://www.genenames.org>
] ;
fhir:code [ fhir:v "ERBB2" ] ;
fhir:display [ fhir:v "Erb-B2 receptor tyrosine kinase 2" ]
] )
]
]
] )
] . #
# -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.